Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug;75(8):1639-1647.
doi: 10.1002/acr.24984. Epub 2023 Mar 2.

Rheumatoid Arthritis Disease Activity and Hospitalized Infection in a Large US Registry

Huifeng Yun  1 , Lang Chen  1 , Jason A Roy  2 , Jeffrey Greenberg  3 , Leslie R Harrold  4 , Michael D George  5 , Jeffrey R Curtis  1
Affiliations

Rheumatoid Arthritis Disease Activity and Hospitalized Infection in a Large US Registry

Huifeng Yun et al. Arthritis Care Res (Hoboken). 2023 Aug.

Abstract

Objectives: The association between disease activity and infection risk among patients with rheumatoid arthritis (RA) is not clear, and it is challenging to determine because of confounding due to the effects of RA treatments and comorbidities.

Methods: Using patients with RA in the CorEvitas registry with Medicare coverage in 2006-2019, we identified eligible patients who had at least 1 visit with moderate disease activity based on the Clinical Disease Activity Index (CDAI; CDAI >10 and ≤22). Follow-up started at the subsequent CorEvitas visit. Hospitalized infection during follow-up was assessed in linked Medicare data. We calculated the incidence rate of hospitalized infection for patients in remission, and low and moderate disease activity, and estimated the effect of time-varying CDAI on hospitalized infection by controlling for baseline and time-dependent confounders using marginal structural models (MSMs).

Results: A total of 3,254 patients with RA were eligible for analysis, among which 529 hospitalized infections were identified during follow-up. The crude incidence of hospitalized infection was 3.8 per 100 person-years for patients in remission, 6.6 for low disease activity, and 8.0 for moderate disease activity. Using MSMs and compared with being in remission, the hazard ratio of hospitalized infection associated with low disease activity was 1.60 (95% confidence interval [95% CI] 1.13-2.28) and with moderate disease activity was 1.83 (95% CI 1.30-2.64).

Conclusion: The risk of hospitalized infection was higher for patients with RA in low or moderate disease activity than for those in remission after accounting for the interplay of disease activity, RA treatments, treatment switching, and other potential confounders.

PubMed Disclaimer

Conflict of interest statement

HY: received research funding from Pfizer for unrelated work. Dr.Yun recently joined GSK, but all the work was done at UAB

JRC: received research funding from Abbvie, Amgen, Bristol Myers Squibb, Corevitas, Janssen, Lilly, Novartis, Myriad, Pfizer, Sanofi, Setpoint, Schipher, UCB and served as a consultant for Abbvie, Amgen, Bristol Myers Squibb, Corevitas, Janssen, Lilly, Novartis, Myriad, Pfizer, Sanofi, Setpoint, Schipher, UCB.

LH: employee and shareholder of CorEvitas LLC; a consultant to AbbVie, Bristol Myers Squibb and Roche; speakers bureau for Bristol Myers Squibb.

JG: employee and shareholder of CorEvitas LLC, and served as a consultant to Pfizer.

Figures

Figure 1:
Figure 1:
Study Design Diagram
Figure 2:
Figure 2:
Cohort Selection diagram NP=Number of Patients; NE=Number of Episodes
See this image and copyright information in PMC

Comment in

References

    1. Iguchi-Hashimoto M, Hashimoto M, Fujii T, Hamaguchi M, Furu M, Ishikawa M, Ito H, Yamakawa N, Terao C, Yamamoto K et al. The association between serious infection and disease outcome in patients with rheumatoid arthritis. Clin Rheumatol 2016, 35(1):213–218. - PubMed
    1. Doran MF, Crowson CS, Pond GR, O’Fallon WM, Gabriel SE: Predictors of infection in rheumatoid arthritis. Arthritis Rheum 2002, 46(9):2294–2300. - PubMed
    1. Yun H, Xie F, Delzell E, Levitan EB, Chen L, Lewis JD, Saag KG, Beukelman T, Winthrop KL, Baddley JW et al. Comparative Risk of Hospitalized Infection Associated With Biologic Agents in Rheumatoid Arthritis Patients Enrolled in Medicare. Arthritis Rheumatol 2016, 68(1):56–66. - PubMed
    1. George MD, Baker JF, Winthrop K, Hsu JY, Wu Q, Chen L, Xie F, Yun H, Curtis JR: Risk for Serious Infection With Low-Dose Glucocorticoids in Patients With Rheumatoid Arthritis : A Cohort Study. Ann Intern Med 2020, 173(11):870–878. - PMC - PubMed
    1. Desai RJ, Bateman BT, Huybrechts KF, Patorno E, Hernandez-Diaz S, Park Y, Dejene SZ, Cohen J, Mogun H, Kim SC: Risk of serious infections associated with use of immunosuppressive agents in pregnant women with autoimmune inflammatory conditions: cohort study. BMJ 2017, 356:j895. - PMC - PubMed

Publication types

Substances

LinkOut - more resources